« Return to News | CROs/Service Providers | Awards & Advancement

CROs Add New People, Positions

Thursday, December 4, 2008 11:33 AM

Although many companies are reducing headcount at an alarming rate, at least a few contract research organizations (CROs) continue to hire new people and create new positions. This week’s personnel news from around the clinical trial industry:

Portage, Mich.-based CRO Eurofins AvTech Laboratories named Jeff Moran director of business development in an effort to enhance client relations and expand AvTech’s bioanalytical reach. Moran has more than eight years of business development experience supporting both bioanalysis and phase I clinical trials.

Camargo Pharmaceutical Services, a CRO in Cincinnati, Ohio, appointed Elaine Taylor as its new director of research services. In this role, Taylor will handle all scientific research writing activities and provide research and regulatory submission support for all stages of drug development. Prior to joining Camargo, Taylor was senior medical writer for Proctor and Gamble.

Ricerca, another Ohio-based CRO, appointed Thomas Davidson, Ph.D., director of toxicology and pharmacology. Davidson is responsible for the work conducted by Ricerca study directors, as well as peer reviews and on-time timely delivery of toxicological reports. Davidson was previously director of toxicology at Enzon Pharmaceuticals.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.